AI medical scribes are changing how Australian doctors document patient consultations. They can prepare clinical notes in minutes, reduce administrative work and help clinicians spend more time speaking with patients rather than typing.
But a faster medical record is not necessarily a more accurate one.
In August 2026, an Australian patient discovered a false claim about illegal drug use in her medical correspondence. Two months later, the Therapeutic Goods Administration (TGA) published findings showing that several digital scribing products had functions potentially requiring medical device regulation.
Meanwhile, Australian clinical studies have documented substantial improvements in documentation efficiency alongside a continuing need for corrections.
For healthcare providers, these developments raise an important question: how can AI medical scribes be used without compromising the accuracy, privacy and reliability of patient records?
Are AI Medical Scribes Safe to Use in Australia in 2026?
AI medical scribes can help healthcare professionals prepare clinical records more efficiently, but they are not free from errors. Australian research published in 2026 found significant reductions in documentation delays, while also showing that clinicians frequently modify generated notes before finalising them.
The TGA regulates certain digital scribe functions when they meet the definition of a medical device. Systems used solely for administrative transcription and documentation generally fall outside that definition.
Regardless of the software used, healthcare practitioners remain responsible for checking the accuracy of the information entered into patient records.
The central concern is not whether AI can transcribe a consultation. It is whether the resulting document accurately reflects what the patient and clinician discussed.
Why AI Medical Scribes Are Gaining Popularity in Australian Healthcare
Clinical documentation is essential to good patient care, but it can take considerable time.
General practitioners must prepare consultation notes, update patient histories, write referrals and communicate with other healthcare professionals. Specialists face similar demands when producing reports, correspondence and follow-up documentation.
AI medical scribes attempt to reduce this workload by capturing conversations and converting them into structured clinical notes.
The technology has attracted growing interest across Australian healthcare.
According to an April 2026 submission from the Royal Australian College of General Practitioners (RACGP), the proportion of respondents reporting AI scribe use in its newsGP polls increased from 22% in August 2024 to 40% in November 2025.
These polls were not nationally representative surveys, but they illustrate the growing interest among Australian GPs.
For practices handling large volumes of clinical reports, automation is understandably attractive. Some healthcare providers are also considering AI transcription services that combine automated processing with human review.
However, the speed of documentation should not be the only factor in selecting a system.
What Australian Clinical Research Reveals About AI Medical Scribes
Two Australian studies published in 2026 offer a useful picture of what AI medical scribes can and cannot deliver.
Queensland Study: Faster Clinical Correspondence
A study conducted through Children's Health Queensland evaluated the introduction of an ambient AI medical scribe across 131 healthcare professionals, including medical practitioners, allied health professionals and nurse practitioners.
Researchers found that the median time to finalise outpatient letters decreased from 7.9 days before implementation to 14 minutes following implementation.
The study also surveyed 71 clinicians about their experiences.
Among respondents:
Researchers also reported approximately A$16,903 in transcription cost savings.
These findings suggest that AI-assisted documentation can help reduce delays in preparing clinical correspondence.
However, the results came from an observational study in a particular healthcare setting. The reduction in letter turnaround time should not be interpreted as equivalent to the amount of time saved typing each document.
The study also found no definitive effect on overtime claims.
Melbourne Study: More Than 1,100 Modifications to Clinical Notes
A separate study at St Vincent's Hospital in Melbourne examined an AI scribe used during 248 emergency department presentations.
Clinicians made 1,143 modifications to the generated notes before submitting the final medical records.
The history of presenting illness and management plan were among the sections most frequently revised.
The researchers estimated documentation time savings, although further research was needed to establish longer-term productivity gains.
Importantly, the 1,143 modifications should not be interpreted as 1,143 clinically harmful errors. They included changes made during the normal review and editing process.
Nevertheless, the findings demonstrate that producing an initial draft is only part of clinical documentation.
Someone still needs to confirm that the record is accurate, complete and clinically meaningful.
For healthcare organisations assessing AI scribes, these studies support a practical distinction: documentation efficiency and clinical accuracy must be measured separately.
The Australian Patient Case That Exposed a Serious Documentation Risk
In August 2026, ABC News reported the experience of Rebecca Green, an Australian patient who agreed to AI transcription during an appointment with a urologist.
After undergoing kidney stone surgery, Green reviewed a specialist letter sent to her GP.
The letter claimed she had been micro-dosing psychedelic mushrooms and suggested that this could have contributed to previous bleeding around her kidneys.
Green said she had never taken psychedelic mushrooms.
The statement was particularly concerning because she was receiving workers' compensation and feared that an incorrect reference to illegal drug use could affect her circumstances.
Following her complaint, the specialist apologised and corrected the correspondence.
The doctor said the precise cause of the incorrect information could not be established, although it appeared to have arisen during the dictation or transcription process.
The publicly reported evidence does not establish exactly how the error occurred. It would therefore be misleading to attribute the mistake to a specific software failure without further information.
Even so, the incident demonstrates the consequences of inaccurate medical documentation.
Why One Incorrect Statement Can Matter
Medical records follow patients across different healthcare settings.
A consultation note may inform a specialist referral. A hospital discharge summary may guide a GP's follow-up decisions. A clinical report may be reviewed during an insurance or legal assessment.
Incorrect information can therefore have consequences beyond the original appointment.
A mistaken medication history, unsupported diagnosis or inaccurate statement about substance use may influence how another professional interprets the patient's circumstances.
This makes careful documentation particularly important for specialist correspondence and medico-legal transcription, where the precise wording of a report can carry legal and clinical significance.
Green's case does not mean AI transcription should be avoided altogether. It demonstrates why clinicians must review documentation before it becomes part of a patient's medical history.
What the TGA Found About Digital Scribes in October 2026
On 16 October 2026, the TGA published the outcomes of its review of digital scribes supplied in Australia.
The regulator identified approximately 100 suppliers through its market review and received responses from 40 suppliers.
It then examined 12 products in greater detail.
The findings revealed that:
- Eight products contained functions likely to meet the definition of a medical device.
- Two required further information to determine their regulatory status.
- Two appeared unlikely to meet the definition of a medical device.
None of the suppliers of the 12 products had identified their products as medical devices.
These findings raised questions about whether suppliers fully understood the regulatory requirements associated with the functions their products offered.
However, the TGA made an important distinction.
Its review did not test the clinical accuracy, safety or performance of the products. It also did not assess their privacy protections.
The findings therefore do not establish that the products were clinically unsafe. They indicate that certain functions may fall within Australia's medical device regulatory framework.
When Is an AI Medical Scribe Considered a Medical Device?
The answer depends on what the software is intended to do.
A digital scribe that records consultations, transcribes speech, organises information or prepares documentation for clinician review will generally be considered an administrative tool.
The position can change when software begins making patient-specific clinical recommendations.
For example, a scribe may fall within medical device regulation if it is intended to:
-
Suggest diagnoses or treatment options.
-
Recommend clinical investigations.
-
Generate clinical assessments or conclusions.
-
Monitor, prioritise or triage patients.
Medical devices generally require inclusion in the Australian Register of Therapeutic Goods (ARTG) before supply, unless an applicable exemption applies.
Certain clinical decision support systems may qualify for specific exemptions, depending on their intended use and functionality.
For Australian healthcare providers, this means that the term AI medical scribe is not enough to establish a product's regulatory position.
Practices need to understand exactly what the system does and whether any additional clinical functions introduce regulatory obligations.
The TGA's October 2026 findings make this distinction particularly relevant for organisations purchasing or upgrading documentation software.
Patient Privacy and Consent Cannot Be Overlooked
Medical consultations routinely involve sensitive personal information.
Patients may discuss medications, mental health, family circumstances, sexual health, substance use or other details that they expect to remain confidential.
When an external technology provider processes these conversations, questions about consent, access and data storage become especially important.
Australian healthcare organisations must consider their obligations under the Privacy Act 1988, the Australian Privacy Principles and other applicable laws.
The Office of the Australian Information Commissioner (OAIC) advises organisations to conduct appropriate privacy due diligence when using commercially available AI products.
Before introducing an AI medical scribe, healthcare providers should understand how consultation data is collected, processed, retained and protected.
That includes establishing whether recordings are stored, whether information is processed overseas and whether it may be used for purposes beyond preparing the patient's medical record.
Consent deserves particular attention.
Patients should receive a clear explanation of how the technology will be used and the choices available to them. Applicable recording laws and professional guidance must also be considered.
A patient who feels uncomfortable with a recording system may be less willing to discuss a sensitive medical concern.
Preserving trust during the consultation matters just as much as protecting the resulting data.
The Documentation Errors Healthcare Providers Need to Watch For
Not every AI transcription error will be as obvious as a misspelled medical term.
Some mistakes can change the clinical meaning of a report while leaving the sentence looking entirely reasonable.
Incorrect Medication Details
Drug names, dosage instructions and medication histories require careful checking.
A transcription error involving a dose or frequency may lead to an inaccurate medication record if it is not corrected.
Missing Clinical Information
A generated summary may omit an important symptom, negative finding, patient concern or follow-up instruction.
The document may appear complete even when relevant information is missing.
Incorrect Clinical Context
AI systems may misunderstand medical abbreviations, specialist terminology or the relationship between different parts of a conversation.
They may also confuse who made a particular statement.
Errors That Sound Convincing
Perhaps the greatest difficulty is that incorrect information can be presented in fluent, professional language.
A clinician reviewing a well-formatted document may not immediately recognise that a statement was never discussed.
The RACGP advises GPs to check AI-generated notes for inaccurate or missing information and to ensure that medical records remain accurate and up to date.
This responsibility continues regardless of how advanced the documentation technology becomes.
AI Scribes vs Human-Reviewed Medical Transcription: Which Is More Appropriate?
There is no single documentation method that suits every healthcare setting.
An ambient AI scribe may be useful for preparing consultation notes during routine appointments. Conventional medical transcription may be more appropriate when clinicians dictate detailed reports from recordings.
Human-reviewed transcription can provide an additional layer of checking, particularly for complex terminology or unclear passages.
A combination of automated transcription and professional review may also be suitable for some reporting workflows.
The important consideration is the type of document being prepared and the consequences of an error.
For example, routine consultation notes may require a different workflow from detailed operative reports, specialist assessments or medico-legal correspondence.
Human transcriptionists can help identify unclear words, check terminology and flag passages that require clarification. They cannot independently verify every clinical fact or replace a doctor's professional judgement.
For Australian healthcare providers, professional medical transcription services remain an option where detailed documentation, specialist terminology and additional transcription review are priorities.
Before selecting a provider, practices should examine how quality assurance is performed, how errors are handled and what measures protect confidential patient information.
A claim of high transcription accuracy is useful only when the provider can explain what that figure measures and how it is assessed.
What Should Australian Healthcare Practices Do Before Adopting an AI Scribe?
The research and regulatory developments of 2026 provide several lessons for healthcare organisations.
First, practices should assess the software against their actual clinical requirements. A product suitable for routine consultation notes may not be appropriate for every specialist report or high-risk clinical interaction.
Second, documentation quality should be evaluated alongside speed. The time saved generating a draft matters less if clinicians must spend substantial time identifying and correcting errors.
Third, the organisation should establish clear rules for reviewing and approving AI-generated notes. Clinicians must understand that a completed draft is not necessarily a final medical record.
Fourth, privacy arrangements and patient consent procedures need to be established before the technology becomes part of routine care.
Finally, practices should review performance after implementation. Monitoring corrections, clinically significant errors and patient feedback can provide a more useful picture of the technology's value than vendor claims alone.
The goal is not to create the fastest possible documentation process. It is to reduce unnecessary administrative work while maintaining reliable clinical records.
Frequently Asked Questions
Can AI medical scribes make mistakes in patient records?
Yes. AI medical scribes can misunderstand conversations, omit relevant details or introduce incorrect statements. Australian research published in 2026 documented substantial clinician editing of AI-generated notes. The RACGP recommends that practitioners carefully review generated records before finalising them.
Are AI medical scribes regulated by the TGA in Australia?
Some are. Digital scribes used only for administrative recording, transcription and summarisation generally do not qualify as medical devices. However, products intended to generate diagnoses, recommend treatments or perform other therapeutic functions may be regulated by the TGA, subject to applicable exemptions.
Who is responsible for the accuracy of AI-generated clinical notes?
The healthcare practitioner remains responsible for ensuring that the clinical record is accurate and appropriate. Using an AI medical scribe does not transfer professional responsibility to the software provider.
Is human-reviewed medical transcription still necessary?
Human-reviewed transcription remains relevant for complex clinical documentation, specialist dictation and reports where additional checking is appropriate. Automated transcription can improve speed, while trained transcriptionists may help identify terminology issues and unclear passages. The treating clinician must still approve the clinical content.
How can Australian clinics protect patient information when using AI scribes?
Clinics should evaluate vendor privacy arrangements, understand where data is processed and stored, establish appropriate consent procedures and comply with applicable privacy and recording laws. The OAIC provides guidance on privacy obligations when using commercial AI systems.
Final Thoughts: Better Documentation Must Remain Accurate Documentation
The evidence emerging from Australia in 2026 shows why AI medical scribes have attracted attention from healthcare professionals.
Clinical studies demonstrate that automated documentation can reduce delays and ease administrative demands. For busy practices, these benefits can make a meaningful difference.
But Rebecca Green's reported experience highlights the personal consequences of an inaccurate medical record.
The TGA's October findings add another consideration: some digital scribe products now perform functions that may extend beyond ordinary transcription and into regulated clinical software.
Together, these developments suggest that Australian healthcare providers need a measured approach to adopting AI documentation tools.
The benefits of automation should be welcomed where they are supported by evidence, but not at the expense of accuracy, privacy or professional responsibility.
Medical documentation is more than an administrative task. It forms part of the clinical record that informs decisions about a patient's care.
For practices considering AI-assisted workflows or traditional transcription, iTranscript360 Australia offers services for different medical reporting needs.
Healthcare organisations can contact iTranscript360 Australia to discuss available transcription options and the review processes suited to their documentation requirements.
The future of medical documentation may involve more automation, but reliable patient records will continue to depend on careful review and informed clinical judgement.
References
- Therapeutic Goods Administration. Digital Scribe Review Outcomes. Published 16 October 2026.
- Therapeutic Goods Administration. Digital Scribes: When They Are Regulated as Medical Devices. Updated 16 October 2026.
- ABC News. Error by AI Scribe During Medical Appointment Leaves Patient Devastated. Published 14 August 2026.
- Kapoor V, et al. Improving Clinical Efficiency Using Artificial Intelligence Scribe for Documentation (ICE-AID Study). Journal of Paediatrics and Child Health, 2026.
- Akhlaghi H, et al. Evaluation of an AI Scribe Tool in the Emergency Department. Emergency Medicine Australasia, 2026.
- Royal Australian College of General Practitioners. Artificial Intelligence (AI) Scribes: Guidance for General Practice.
- Office of the Australian Information Commissioner. Guidance on Privacy and the Use of Commercially Available AI Products.